YNCRG Alleviated Hepatic Steatosis in Metabolic Syndrome Model Rats by Improving Lipid Metabolism and Chronic Inflammatory Reaction
Abstract
(ISSN 2573-4393)
OBM Integrative and Complementary Medicine is an international peer-reviewed Open Access journal published quarterly online by LIDSEN Publishing Inc. It covers all evidence-based scientific studies on integrative, alternative and complementary approaches to improving health and wellness.
Topics contain but are not limited to:
It publishes a variety of article types: original research, review, communication, opinion, case report, study protocol, comment, conference report, technical note, book review, etc.
There is no restriction on paper length, provided that the text is concise and comprehensive. Authors should present their results in as much detail as possible, as reviewers are encouraged to emphasize scientific rigor and reproducibility.
Archiving: full-text archived in CLOCKSS.
Rapid publication: manuscripts are undertaken in 11.7 days from acceptance to publication (median values for papers published in this journal in the second half of 2021, 1-2 days of FREE language polishing time is also included in this period). A first decision provided to authors of manuscripts submitted to this journal are approximately 6.8 weeks (median values) after submission.
Special Issue
Metabolic Syndrome
Submission Deadline: May 31, 2021 (Open) Submit Now
Guest Editor
Damian Skrypnik, MD, PhD
Department of Treatment of Obesity, Metabolic Disorders and Clinical Dietetics, Poznan University of Medical Sciences, Poznan, Poland
Research Interests: Abdominal obesity; metabolic syndrome; metabolic diseases; hypertension; diabetes; physical exercise; cardiac rehabilitation
About this Topic
“(…) no one will ever be free so long as there are pestilences.”
Albert Camus, The Plague
It is calculated that even 25% of adult population worldwide presents diagnostic criteria of metabolic syndrome. World Health Organization reports that the majority of the world’s population live in countries where excess body mass, a reason of metabolic syndrome, kills more people than underweight. This “silent epidemic” may increase the risk of all-cause-mortality even by 8 fold.
“Metabolic Syndrome”, a special issue of OBM Integrative and Complementary Medicine, will present a current state of knowledge on this health- and life threatening disorder. The issue will gather a crucial and innovative researches in the range of complementary medicine involved in the treatment of metabolic syndrome and obesity. The main scopes of the issue are: obesity and overweight and excess body mass derived diseases: arterial hypertension, dyslipidemia, diabetes and pre-diabetes. Both diagnostic and therapeutic approach is well seen. The Editorial Board invites the authors to submit their valuable studies. Also, please feel free to contact the Editorial Board in case of any questions.
Damian Skrypnik
Department of Treatment of Obesity, Metabolic Disorders and Clinical Dietetics,
Poznan University of Medical Sciences, Poznan, Poland
Submission
Manuscripts should be submitted online at http://www.lidsen.com/account-login by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. Guidelines for authors and other relevant information for submission of manuscripts are available on the Instructions for Authors page. OBM Integrative and Complementary Medicine is an international peer-reviewed Open Access monthly journal published by LIDSEN. Please visit the Instructions for Authors page before submitting a manuscript.
Publication
YNCRG Alleviated Hepatic Steatosis in Metabolic Syndrome Model Rats by Improving Lipid Metabolism and Chronic Inflammatory ReactionAbstract YNCRG is a combination of five traditional Chinese ingredients with medicinal properties. We studied its effects and mechanism of action on a rat model of non-alcoholic fatty liver with metabolic syndrome. Eight-week-old male SHRcp rat(s) and Wister Kyoto (WKY) rats were adaptively fed for one week, after which they were randomly divided into [...] |
Improving Diabetes Outcomes with a Multimodal Intervention for Less Advantaged Adults with Type 2 Diabetesby
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Abstract If proper self-management behaviors are not maintained, diabetes may lead to reduced quality of life (QoL), decreased engagement in everyday activities, disabling health complications, and even death. Less advantaged adults with limited income, lower education, and fewer resources find diabetes self-management (DSM) particularl [...] |
Metabolic Syndrome and Erectile DysfunctionAbstract Metabolic syndrome (MetS) is considered a risk factor for erectile dysfunction (ED), and ED is almost three times more prevalent in men with MetS. Vascular pathologies are a significant factor for the development of ED, and many experts suggest endothelial dysfunction (EnD) as a likely explanation for the association between ED [...] |
TOP